Rise in Number of Cardiovascular Surgery around the Globe is Impelling the Growth of the Micro Guide Catheters Market

 

Micro guide catheters are used in order to guide the urethra so that you can have an easy time inserting your pet's urethra and not be worried about any kind of blockage at all. There are many types of these devices available in the market. Some of these are manual tube and electric as well. Many people prefer to use micro guide catheters because they are made very simply and with great ease of use.

A growing number of surgical procedures for treating cardiovascular diseases is fueling the growth of the micro guide catheters market. According to the American College of Cardiology Foundation, in 2017, emergency medical services-assessed out-of-hospital cardiac arrest occurred in an estimated 356,461 Americans; emergency medical services treatment was initiated in 52%. In the United States in 2019, coronary events are expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events. The increasing development of modern disposable catheters that are safer and more comfortable to insert is further projected to foster the growth of the micro guide catheters market.

North America is projected to gain significant growth over the forecast period and this is attributed to the continuous launch of innovative products by ley players in the region. For instance, in March 2017, Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and the U.S. commercial launch of the TrapLiner Catheter. The TrapLiner Catheter was developed by Vascular Solutions Inc., which was acquired by Teleflex.

Key Developments:

1.      In May 2019, Medtronic announced the launch of the Telescope guide extension catheter, to provide backup support and access to distal lesions. This marks the med-tech major’s foray into the guide extension catheter market.

2.      In August 2018, S3V Vascular Technologies Private Limited, a medical devices manufacturing company launched Nextgen PTCA (Percutaneous Transluminal Coronary Angioplasty) Balloon Catheters into the domestic market. PTCA is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle.

3.      In March 2020, Zeus Industrial Products, Inc. (Zeus), a polymer solutions provider and material science innovator has expanded its StreamLiner™ family of thin, extruded PTFE catheter liners. The new StreamLiner OTW UT, the thinnest extruded liner yet, offers a nominal wall thickness as low as 0.0004" (0.0102 mm) with a tolerance of +/- 0.0002" (0.0051 mm).